Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 4
2020 2
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Yang F, Long N, Anekpuritanang T, Bottomly D, Savage JC, Lee T, Solis-Ruiz J, Borate U, Wilmot B, Tognon C, Bock AM, Pollyea DA, Radhakrishnan S, Radhakrishnan S, Patel P, Collins RH, Tantravahi S, Deininger MW, Fan G, Druker B, Shinde U, Tyner JW, Press RD, McWeeney S, Agarwal A. Yang F, et al. Among authors: anekpuritanang t. Blood. 2022 Feb 24;139(8):1208-1221. doi: 10.1182/blood.2021011354. Blood. 2022. PMID: 34482403 Free PMC article. Clinical Trial.
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Anekpuritanang T, Klairmont MM, Gradowski J, Hagiwara K, Bailey NG, Chandra P, Liu Y, Mulder HL, Easton J, Zhang J, Martin MG, Owczarczyk AB, Dunlap JB, Fan G, Press RD, Raess PW. Anekpuritanang T, et al. Blood Adv. 2021 Dec 14;5(23):5057-5059. doi: 10.1182/bloodadvances.2021004983. Blood Adv. 2021. PMID: 34559205 Free PMC article. No abstract available.
Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma.
Bunbanjerdsuk S, Vorasan N, Saethang T, Pongrujikorn T, Pangpunyakulchai D, Mongkonsiri N, Arsa L, Thokanit N, Pongsapich W, Anekpuritanang T, Ngamphaiboon N, Jinawath A, Sunpaweravong S, Pisitkun T, Suktitipat B, Jinawath N. Bunbanjerdsuk S, et al. Among authors: anekpuritanang t. Mod Pathol. 2019 Jul;32(7):943-956. doi: 10.1038/s41379-019-0211-2. Epub 2019 Feb 8. Mod Pathol. 2019. PMID: 30737471 Free article.
High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer.
Korphaisarn K, Pongpaibul A, Roothumnong E, Pongsuktavorn K, Thamlikitkul L, Anekpuritanang T, Poungvarin N, Thongnoppakhun W, Pithukpakorn M. Korphaisarn K, et al. Among authors: anekpuritanang t. Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2319-2326. doi: 10.31557/APJCP.2019.20.8.2319. Asian Pac J Cancer Prev. 2019. PMID: 31450901 Free PMC article. Clinical Trial.
11 results